LATIN AMERICA NEXT GENERATION SEQUENCING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-44182 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Latin America Next Generation Sequencing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET
7.1 GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Illumina, Inc.
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Thermo Fisher Scientific Inc.
16.3 Pacific Biosciences of California, Inc.
16.4 Qiagen N.V.
16.5 Oxford Nanopore Technologies Ltd
16.6 Bio-Rad Laboratories, Inc.
16.7 Beckman Coulter, Inc.
16.8 PerkinElmer, Inc.
16.9 F. Hoffmann-La Roche AG
16.10 10x Genomics, Inc. .
16.11 Macrogen Inc.
16.12 Partek Inc.
16.13 Agilent Technologies Inc.
16.14 Genomatix Software GmbH
16.15 GATC Biotech Ag
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeConsumables
 o Sample Preparation Consumables
   o DNA Fragmentation & Amplification
   o Library Preparation & Target Enrichment
   o Quality Control
 o Other Consumables
NGS Platforms/Instruments
 o Illumina NGS Platforms/Instruments
 o Thermo Fisher Scientific NGS Platforms/Instruments
 o Pacific Biosciences NGS Platforms/Instruments
 o Oxford Nanopore NGS Platforms/Instruments
 o Others
Software
Services
By Sequencing Type
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing
Others
By Technology
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Others
By Application
Clinical Application
 o Oncology
 o Reproductive Health Diagnostics
   o Non-Invasive Pre-natal Testing
   o Carrier Screening
   o In-Vitro fertilization
   o Newborn Screening
 o Cardiovascular
 o Others
Research Application
 o Drug Discovery
 o Agriculture & Animal Research
 o Others
By End user
Clinical Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Companies
Illumina, Inc.
Thermo Fisher Scientific Inc.
Pacific Biosciences of California, Inc.
Qiagen N.V.
Oxford Nanopore Technologies Ltd
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc.
PerkinElmer, Inc.
F. Hoffmann-La Roche AG
10x Genomics, Inc. .
Macrogen Inc.
Partek Inc.
Agilent Technologies Inc.
Genomatix Software GmbH
GATC Biotech Ag
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.